Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RIGL | ZTS | TAK | UTHR | NBIX |
| Company | Rigel Pharmaceuticals | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.1900 | 151.12 | 13.31 | 233.21 | 134.97 |
| High | 1.1900 | 155.00 | 13.35 | 237.93 | 137.00 |
| Low | 1.1400 | 149.24 | 13.17 | 232.79 | 131.52 |
| Last | 1.1500 | 149.77 | 13.18 | 235.08 | 131.74 |
| Change | -0.0500 | -0.21 | -0.19 | +2.49 | -2.92 |
| % Change | -4.17% | -0.14% | -1.42% | +1.07% | -2.17% |
| Volume | 768,500 | 8,667,399 | 1,788,800 | 328,000 | 767,200 |
| 20-Day Average Volume | 1,574,065 | 3,857,745 | 1,822,830 | 524,255 | 853,850 |
| Previous Close | 1.2000 | 149.98 | 13.37 | 232.59 | 134.66 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3360 | 165.40 | 13.89 | 236.11 | 138.77 |
| 20-Day Raw Stochastic | 2.74% | 4.99% | 0.69% | 46.15% | 1.31% |
| 20-Day Relative Strength | 37.57% | 25.45% | 32.21% | 51.79% | 41.32% |
| Weighted Alpha | -9.43 | -21.51 | -22.19 | +3.74 | +27.51 |
| Today's Opinion | 8% Buy | 88% Sell | 100% Sell | 80% Buy | 40% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 100% Sell | 80% Buy | 64% Buy |
| Last Month's Opinion | 56% Buy | 8% Sell | 40% Sell | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.73% since 04/08/24 | -9.61% since 04/08/24 | -3.58% since 04/08/24 | -0.79% since 04/08/24 | -5.52% since 04/08/24 |
| Low | 1.1400 on 04/15/24 | 148.48 on 04/12/24 | 13.17 on 04/15/24 | 232.40 on 04/12/24 | 131.52 on 04/15/24 |
| High | 1.3000 on 04/09/24 | 167.18 on 04/09/24 | 13.69 on 04/09/24 | 241.37 on 04/11/24 | 141.45 on 04/09/24 |
| 1-Month | |||||
| %Chg | -15.44% since 03/15/24 | -13.21% since 03/15/24 | -8.91% since 03/15/24 | -0.30% since 03/15/24 | -5.29% since 03/15/24 |
| Low | 1.1400 on 04/15/24 | 148.48 on 04/12/24 | 13.17 on 04/15/24 | 221.53 on 04/01/24 | 131.52 on 04/15/24 |
| High | 1.5050 on 03/28/24 | 174.33 on 03/21/24 | 14.61 on 03/18/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 3-Month | |||||
| %Chg | -13.53% since 01/12/24 | -24.72% since 01/12/24 | -12.37% since 01/12/24 | +7.32% since 01/12/24 | -0.22% since 01/12/24 |
| Low | 1.0810 on 02/08/24 | 148.48 on 04/12/24 | 13.17 on 04/15/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 1.7300 on 03/06/24 | 200.53 on 02/29/24 | 15.03 on 01/16/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +22.31% since 10/13/23 | -14.11% since 10/13/23 | -12.95% since 10/13/23 | +0.82% since 10/13/23 | +16.75% since 10/13/23 |
| Low | 0.7120 on 10/25/23 | 148.48 on 04/12/24 | 13.17 on 04/15/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 1.7300 on 03/06/24 | 201.92 on 12/14/23 | 15.08 on 10/16/23 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 210,486 | 68,594,704 | 42,313,620 | 10,945,450 | 13,399,614 |
| Shares Outstanding, K | 175,405 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 116,880,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -25,090,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 35,790,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | 740,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 0.95 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/05/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 01/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.19 | 6.86 | 11.72 | 55.64 |